Find information on thousands of medical conditions and prescription drugs.

Osteoporosis

Osteoporosis is a disease of bone in which bone mineral density (BMD) is reduced and bone microarchitecture is disrupted. Osteoporotic bones are susceptible to fracture. It is defined according to the bone mineral density as measured by DEXA: a BMD of 2.5 standard deviations below the peak bone mass (20-year-old person standard) is indicative of osteoporosis. While treatment modalities are becoming available, prevention is still the most important way to reduce fracture. Due to its hormonal component, more women suffer from osteoporosis than men. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
Obesity
Obsessive-compulsive...
Occipital horn syndrome
OCD
Ochronosis
Oculocutaneous albinism,...
Oculopharyngeal muscular...
Odontophobia
Odynophobia
Oikophobia
Olfactophobia
Olivopontocerebellar atrophy
Omenn syndrome
Onchocerciasis
Oncocytoma
Ondine's curse
Opportunistic infections
Oppositional defiant...
Optic atrophy
Optic neuritis
Oral leukoplakia
Ornithosis
Orthostatic intolerance
Osgood-Schlatter disease
Osteitis deformans
Osteoarthritis
Osteochondritis
Osteochondritis dissecans
Osteochondroma
Osteogenesis Imperfecta
Osteomalacia
Osteomyelitis
Osteopetrosis, (generic...
Osteoporosis
Osteosclerosis
Otosclerosis
Otospondylomegaepiphyseal...
Ovarian cancer
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Signs and symptoms

Clinical picture

Osteoporotic fractures are those that occur under slight amount of stresses that would not normally lead to fractures in nonosteoporotic people. Typical fractures occur in the vertebral column, hip and wrist. Collapse of vertebrae ("compression fracture") leads to chronic pain, characteristic bent stature, and decreased pulmonary function (ability to breathe) while the fractures of the long bones acutely impair mobility and may require surgery. Hip fracture, in particular, carries a poor prognosis.

While osteoporosis may occur in men, the problem is overwhelmingly prevalent in postmenopausal women.

Risk factors

Risk factors for osteoporotic fracture can be split between modifiable and non-modifiable:

  • Nonmodifiable: history of fracture as an adult, family history of fracture, female sex, advanced age, European ancestry, and dementia
  • Potentially modifiable: prolonged intake of the prescription drug prednisone, tobacco smoking, intake of soft drinks (containing phosphoric acid), low body weight <58 kg (127 lb), estrogen deficiency, early menopause (<45 years) or bilateral oophorectomy, prolonged premenstrual amenorrhea (>1 year), low calcium and vitamin D intake, alcoholism, impaired eyesight despite adequate correction, recurrent falls, inadequate physical activity (i.e. too little or also if done in excess), high risk of falls, poor health/frailty.

Diagnosis

Dual energy X-ray absorptiometry (DXA, formerly DEXA) is considered the gold standard for diagnosis of osteoporosis. Diagnosis is made when the bone mineral density is equal to or greater than 2.5 standard deviations below that of a young adult reference population. This is translated as a T-score. The World Health Organization has established diagnostic guidelines as T-score -1.0 or greater is "normal", T-score between -1.0 and -2.5 is "low bone mass" (or "osteopenia") and -2.5 or below as osteoporosis. A low trauma or osteoporotic fracture, defined as one that occurs as a result of a fall from a standing height, is also diagnostic of osteoporosis regardless of the T-score.

In order to differentiate between "primary" (post-menopausal, regardless of age, or senile - related to age) and "secondary" osteoporosis, blood tests and X-rays are usually done to rule out cancer with metastasis to the bone, multiple myeloma, Cushing's disease and other causes mentioned above.

Etiology

Estrogen deficiency following menopause causes a rapid reduction in BMD. This, plus the increased risk of falling associated with aging, leads to fractures of the wrist, spine and hip. Other hormone deficiency states can lead to osteoporosis, such as testosterone deficiency. Glucocorticoid or thyroxine excess states also lead to osteoporosis. Lastly, calcium and/or vitamin D deficiency from malnutrition increases the risk of osteoporosis.

Read more at Wikipedia.org


[List your site here Free!]


Most women treated for osteoporosis are deficient in vitamin D
From OB/GYN News, 11/1/05 by Miriam E. Tucker

WASHINGTON -- More than half of North American women receiving treatment for osteoporosis have suboptimal serum vitamin D levels, Anne E. de Papp, M.D., and her associates reported in a poster at the annual meeting of the American Association of Clinical Endocrinologists.

Inadequate vitamin D concentrations can lead to alterations in calcium and phosphate homeostasis, secondary hypoparathyroidism, bone loss, osteoporosis, and an increased risk of fractures.

Yet, data from a cross-sectional study of 1,536 postmenopausal women at 61 North American sites suggest the problem is often overlooked in osteoporosis patients, said Dr. de Papp, of Merck & Co. Inc., West Point, Pa., and her associates.

"We advocate the use of vitamin D supplementation and patient counseling regarding the importance of vitamin D in all women with osteoporosis," they said in the poster.

The patients had a mean age of 71 years (range, 47-103 years) and a mean body mass index (BMI) of 26.4 kg/[m.sup.2]. A total of 92% were Caucasian and 35% resided at latitude greater than or equal to 42[degrees]N (Boston), while 24% lived below 35[degrees]N (Memphis). All had been taking medication to treat or prevent osteoporosis for at least 3 months. The medications used included alendronate, calcitonin, etidronate, raloxifene, risedronate, and teriparatide.

Vitamin D supplementation at 400 IU / day or more was reported by 59.5%. The rest were taking less. The mean serum level of the active vitamin D metabolite 25-hydroxyvitamin D was 30.4 ng/ mL. Most (52%) had levels below 30 ng/mL, the minimum to maintain optimal serum parathyroid hormone levels (Osteoporos Int. 1997;7:439-43), while 36% had 25-hydroxyvitamin D levels below 25 ng/ mL, and 18% were below 20 ng/mL. Suboptimal 25-hydroxy vitamin D levels were found in 63% taking less than 400 IU / day of vitamin D, and in 45% of those receiving 400 IU or more per day.

Risk factors include having less than a 12th-grade education, lack of exercise, concomitant medication use, BMI of 30 or higher, nonwhite race, and age over 80 years.

The study was funded by Merck.

BY MIRIAM E. TUCKER

Senior Writer

COPYRIGHT 2005 International Medical News Group
COPYRIGHT 2005 Gale Group

Return to Osteoporosis
Home Contact Resources Exchange Links ebay